About

Publications While At HealthPartners

selected publications

Journal Article

Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: patient-reported outcomes in ECOG-ACRIN EA1131. 

Cancer. 2024

Randomized phase III postoperative trial of platinum-based chemotherapy versus capecitabine in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: ECOG-ACRIN EA1131. 

Journal of Clinical Oncology. 2021

Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: results of PrE0102. 

Journal of Clinical Oncology. 2018

Contact

full name

J. A. Sparano

Quick Info

 

Collaboration

Co-author network

Map of science